Latest Insights on FATE
The Real Question for the $63 Billion AbbVie-Allergan Acquisition
June 25, 2019 Great Stuff
I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]The Clash Over Interest Rates
June 17, 2019 Great Stuff
Jerome, you’ve got to let me know. Should I stay or should I go? The Federal Open Market Committee is meeting this week to decide the fate of U.S. monetary policy. In other words, the Fed is looking at interest rates. Federal Reserve Chairman Jerome Powell will hand down the central bank’s decision on Wednesday […] Buy and Hold Stock Strategies Are Dead — but There’s Good News
May 13, 2019 Stocks, Trading Strategies, Winning Investor Daily
Investors have enjoyed a unique time in history. Now they need to adapt. And active strategies present the best opportunities. 1 Cannabis Trend to Watch in 2019
May 11, 2019 American Investor Today, Cannabis, Oil
Charles Mizrahi and Anthony Planas share one innovative trend to fully usher pot into the mainstream. (3-minute read) Caution: Natural Resource Stocks Are Dropping — We Can Guide You
February 15, 2019 American Investor Today
The cyclicality of natural resources seems to attract dangerous manias. But we don’t follow the herd to the day’s hot bet. We help investors navigate the natural resource space.